Shape-changing enzyme suggests how small doses of anti-HIV drug might treat Alzheimer's

For a promising pathway to treating Alzheimer’s patients, “aim here.” That’s what National Institute of Standards of Technology (NIST) researchers advised collaborators hunting for molecules that, by linking to a normally occurring enzyme, rev up the brain’s capacity for clearing cholesterol—a boost associated with improvements in memory and other benefits in animal studies.

from Dementia Big http://ift.tt/291vIaF via alcoholic dementia

http://ift.tt/291QaHJ